bioutah
-
BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC
BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC
-
Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
BioUtah president and CEO, Kelvyn Cullmore, recently penned an op-ed published in the Deseret News.
-
This plan to cut drug prices could result in lost jobs and fewer medicines
By Kelvyn Cullimore For the Deseret News
-
Still on the Hill…
BioUtah continues to monitor issues of importance to our industry and engage with legislators on Utah’s Capitol Hill.
-
What Makes Utah One of the Fastest Growing Life Sciences Hubs in America?
Utah’s life sciences community is an economic force, with over 1,000 companies, employing 130,000 Utahns, directly and indirectly, and generating $13…
-
Utah Legislators Launch Life Sciences Caucus
Utah legislators on Wednesday kicked-off the new Utah Life Sciences Innovation Caucus (ULSIC) with a meeting at the…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
